Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-06
2007-03-06
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356100, C548S364100, C546S268100, C546S275400, C514S403000
Reexamination Certificate
active
10490549
ABSTRACT:
The invention relates to a group of novel 2,3 diaryl-pyparazolidine derivatives having formula (1). The symbols used in formula (1) have the meanings given in the specification. The compounds have inhibiting activity on enzymes which degrade the neuropeptide neurotensin and can be used for the treatment of affections and diseases caused by disturbances of the neurotensin mediated transmission.
REFERENCES:
patent: 4912127 (1990-03-01), Henning et al.
patent: 5502059 (1996-03-01), Labeeuw et al.
patent: 5585497 (1996-12-01), Labeeuw et al.
patent: 0 647 629 (1995-04-01), None
Feenstra Roelof W.
Keizer Hiskias
Kruse Cornelis G.
Lange Josephus H. M.
Pras-Raves Maria L.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Shameem Golam M. M.
Solvay Pharmaceuticals B.V.
LandOfFree
Neurotensin active 2,3,diaryl-pyrazolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurotensin active 2,3,diaryl-pyrazolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotensin active 2,3,diaryl-pyrazolidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791048